by admin | Jul 5, 2026 | Q-Patient Journeys - Video
During the Patient Session at the 8th TWC in Cape Town, South Africa, on Jan 29, 2026, two patients and two caregivers came together to share their experiences. The Session entitled “Enhancing Global Access To Radioligand Therapy (RLT) For Everyone” was...
by admin | Jul 3, 2026 | Q-Latest Events
The chairs, Prof. Richard P. Baum and Prof. Frederik L. Giesel, guided participants through the latest scientific and clinical developments, shaping the future of Radiotheranostics. The first day focused on the rapidly advancing field of alpha emitters, with...
by admin | Jul 3, 2026 | Q-Latest Events
Over 220 experts from 27 countries came together to shape the future of radiotheranostics for better cancer patient outcomes. This biannual conference brought together a broad spectrum of stakeholders – from academia, industry, patient advocacy groups and professional...
by admin | Jul 3, 2026 | Q-Research Grants
This project aims to utilize 177Lu and 225Ac conjugated with FAP for targeted imaging and therapy in solid tumors, focusing on cancer-associated fibroblasts (CAFs). Additionally, it seeks to investigate the synergistic effects of PD-L1 immunotherapy or chemotherapy...
by admin | Jul 3, 2026 | Q-Research Grants
Immune checkpoint inhibitor (ICI) therapy targeting the PD-1/PD-L1 axis is a very promising treatment option for cancer therapy. However, since only ca. 30% of patients respond to ICI therapy, a diagnostic tool is highly sought after to identify those patients prior...
